At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
Low-level laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Low-level Laser in Treatment of Head and Neck Chronic Lymphedema: A Pilot Randomized Controlled Trial
In Brief
A clinical study evaluating Low-level laser for Head and Neck Cancer and 2 related conditions. Completed, enrolled 25 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the effect of low-level laser treatment (LLLT) on the severity of lymphedema, symptom burden, functional status, and quality of life in HNC survivors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Cancer, Lymphedema, Fibrosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedJul 2020
Enrollment StartAug 2021
Primary CompletionJun 2023
Study CompletionJun 2023
TodayJul 2026
First PostedJul 23, 2020
Enrollment StartAug 19, 2021
Primary CompletionJun 1, 2023
Study CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.9 years ago
Interventions
Low-level laserdevice
Low-level laser therapy